Delivery Order SPE2DB22D2211-SPE2DB25FSESY
Award Date 9/11/25
Potential Completion Date 9/12/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,129.04 to AmerisourceBergen Drug Corp for 180 tablets of Acamprosate Calcium 333 mg, with an ultimate completion date of September 15, 2025. This non-competitive, firm fixed-price delivery order was issued on September 13, 2025, with performance to take place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- This is a $1,064.52 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 180 tablets of Acamprosate Calcium 333 mg, a medication used to treat alcohol dependence. The contract is not set aside and was awarded on May 15, 2025, with a completion date of May 16, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,217.28 delivery order is for 180 tablets of acamprosate calcium delayed-release 333 mg, a medication used to treat alcohol dependence. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred forty thousand three hundred thirty-seven dollars to Amerisourcebergen Drug Corporation for the provision of three hundred thirty-three milligram tablets of acamprosate calcium in one hundred eighty count bottles. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over the period of September 19th through September 20th, 2023. The prime contractor, a division of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,774.20 firm fixed-price contract is for the delivery of 180-count bottles of Acamprosate Calcium 333mg tablets, a medication used to treat alcohol dependence. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and...
- This federal contract award, with ID SPE2DB22D3301|SPE2DB24FX6WP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,755.18 firm fixed-price delivery order is for the supply of 180 tablets of Acamprosate Calcium delayed-release 333 mg. The contract has a completion date of December 12, 2023 and was awarded on December 11, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- The Defense Logistics Agency awarded a $1,777.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 12 mg tablets (30-count units), with a completion deadline of June 2, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $3,789.82 to AmerisourceBergen Drug Corp for the supply of Aplenzin ER 174 mg tablets (30-count packaging) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Amphetamine Mix Tablets 20mg, valued at $1,989.00. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,932.05 on September 12, 2025, for the supply of Methylphenidate ER 36 mg tablets (100 count) to support federal medical procurement needs. The award is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of September 15, 2025, and is not designated as a set-aside contract. The contract is performed at the...